Moser, Justin C.
Bhatia, Shailender
Amin, Asim
Pavlick, Anna C.
Betts, Keith A.
Du, Ella Xiaoyan
Poretta, Tayla
Shelley, Karishma
Srinivasan, Swetha
Sakkal, Leon Alan
Palaia, Jennell
Lobo, Maurice
Pe Benito, Melanie
Linton, Joshua A.
Chen, Yan
Xu, Churong
Yin, Lei
Sundar, Manasvi
Weber, Jeffrey
Funding for this research was provided by:
Bristol Myers Squibb
Article History
Received: 29 November 2023
Accepted: 1 April 2024
First Online: 7 May 2024
Declarations
:
: JCM reports receiving medical writing support for this work from Bristol Myers Squibb; research grants (to institution) from Agenus, Alpine Immune Sciences, Amgen, BioEclipse Therapeutics, Fate Therapeutics, Fujifilm, Genentech, Ideaya Biosciences, ImmuneSensor, Iovance, Istari Oncology, Nektar Therapeutics, Novocure, Repertoire Immune Medicines, Rubius, Senhwa Biosciences, Simcha, Storm Therapeutics, Synthorx Inc, Trishula Therapeutics, TScan, University of Arizona, Werewolf Therapeutics, and Y-mAbs; consulting fees from Adagene, Amunix, Boxer Capital, Bristol Myers Squibb, Genome Insight, Imaging Endpoints, Incyte, IQVIA, Oberland, Capital, and Thirona Bio; and payment or honoraria from Caris Life Sciences, Daiichi Sankyo, Immunocore, and TGen. SB reports receiving consulting advisory board/consulting fees from Bristol Myers Squibb, Castle Biosciences, EMD Serono, Exicure, Genentech, Incyte, and Sanofi-Genzyme; research grants (to institution) from 4SC, Amphivena Therapeutics, Bristol Myers Squibb, Checkmate Pharmaceuticals, EMD Serono, Exicure, Immune Design, Incyte, Merck, NantKwest, Nektar, Novartis, OncoSec, Regeneron, and Xencor; and holding stock in Moderna. AA reports receiving medical writing support for this work from Bristol Myers Squibb; payment for speaker bureau from Bristol Myers Squibb; support for attending meetings and/or travel from Bristol Myers Squibb and Merck; and personal fees for participation on data safety monitoring boards or advisory boards from Bristol Myers Squibb, Eisai, Merck, and Sanofi. ACP reports receiving medical writing support for this work from Bristol Myers Squibb; payment for speaker bureau from Bristol Myers Squibb; and consulting fees from Bristol Myers Squibb. KAB reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of the Analysis Group Inc., which provided research and consulting services to Bristol Myers Squibb for this work. EXD reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of the Analysis Group Inc., which provided research and consulting services to Bristol Myers Squibb for this work. TP reports receiving medical writing support for this work from Bristol Myers Squibb, being an employee of and holding stock in Bristol Myers Squibb, and being an employee of Rutgers University. KS reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of Bristol Myers Squibb. SS reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of and holding stock in Bristol Myers Squibb. LAS reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of Bristol Myers Squibb. JP reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of and holding stock in Bristol Myers Squibb. ML reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of and holding stock in Bristol Myers Squibb. MPB reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of and holding stock in Bristol Myers Squibb. JAL reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of Bristol Myers Squibb. YC reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of the Analysis Group Inc., which provided research and consulting services to Bristol Myers Squibb for this work. CX reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of the Analysis Group Inc., which provided research and consulting services to Bristol Myers Squibb for this work. LY reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of the Analysis Group Inc., which provided research and consulting services to Bristol Myers Squibb for this work. MS reports receiving medical writing support for this work from Bristol Myers Squibb and being an employee of the Analysis Group Inc., which provided research and consulting services to Bristol Myers Squibb for this work. JW reports receiving medical writing support for this work from Bristol Myers Squibb; receiving consulting fees from AstraZeneca, Biond Biologics, Celldex, EMD Serono, Evaxion Biotech, Genentech, GSK, ImCheck, Incyte, Merck, Moderna, Nektar, Novartis, Pfizer, Regeneron, and Sellas; receiving consulting fees for advisory board membership from Bristol Myers Squibb; holding equity in Biond Biologics, Evaxion, OncoC4, and Instil Bio; receiving consulting fees for scientific advisory boards from Biond Biologics, CytomX, ImCheck, Incyte, Instil Bio, Neximmune, OncoC4, and Sellas; receiving research grants (to institution) from AstraZeneca, Bristol Myers Squibb, GSK, Moderna, Merck, Novartis, and Pfizer; and royalties for patents from Moffitt Cancer Center and Biodesix.
: Not applicable.
: This study did not require review and approval by ethics committees or informed consent.